ACA / TRY

ACA / USDT

ONDO / IDR

XRP / MXN

BERA / TRY

BERA / USDC

BERA / USDT

PROVE / USDC

PROVE / USDT

PROVE / TRY

CHESS / USDT

CHESS / USDC

POL / IDR

TAO / IDR

TRX / XRP

DF / USDT

NOM / FDUSD

XNO / BTC

GHST / USDT

TRX / ETH

NIRAJ ISPAT IND LTD

PRESSTONIC ENGINEERING L

KAY CEE ENERGY & INFRA L

APOLLO PIPES LIMITED

IZMO LIMITED

LOYAL TEXTILE MILLS LTD

SRIVARI SPICES N FOODS L

SHUBHSHREE BIOFUELS ENE L

HITACHI ENERGY INDIA LTD

CONCORD BIOTECH LIMITED

GROWWAMC - GROWWSLVR

GROWWAMC - GROWWGOLD

CL EDUCATE LIMITED

USHANTI COLOUR CHEM LTD

MAHESHWARI LOGISTICS LTD.

SOLARA ACTIVE PHA SCI LTD

ASHAPURA MINECHEM LTD

BABA FOOD PROCESSING

SILGO RETAIL LTD

TRACXN TECHNOLOGIES LTD

Click here to get full coverage on Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?  simplywall.st

Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

Click here to get full coverage on Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB) - simplywall.st

Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB)  simplywall.st

Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB) - simplywall.st

Click here to get full coverage on India's Divi's Laboratories up; Citi calls it their 'top pick' - TradingView

India's Divi's Laboratories up; Citi calls it their 'top pick'  TradingView

India's Divi's Laboratories up; Citi calls it their 'top pick' - TradingView

Click here to get full coverage on Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr  Business Standard

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr - Business Standard

Click here to get full coverage on Divi’s Laboratories Announces Trading Window Closure - TipRanks

Divi’s Laboratories Announces Trading Window Closure  TipRanks

Divi’s Laboratories Announces Trading Window Closure - TipRanks

Click here to get full coverage on Trade Setup – MTARTECH, LODHA & DIVISLAB - Moneymunch

Trade Setup – MTARTECH, LODHA & DIVISLAB  Moneymunch

Trade Setup – MTARTECH, LODHA & DIVISLAB - Moneymunch

Click here to get full coverage on Divi's Labs Q2 profit rises 35% YoY to Rs 689 crore; shares slip nearly 4% - Business Today

Divi's Labs Q2 profit rises 35% YoY to Rs 689 crore; shares slip nearly 4%  Business Today

Divi's Labs Q2 profit rises 35% YoY to Rs 689 crore; shares slip nearly 4% - Business Today

Click here to get full coverage on Investors Shouldn't Be Too Comfortable With Divi's Laboratories' (NSE:DIVISLAB) Earnings - simplywall.st

Investors Shouldn't Be Too Comfortable With Divi's Laboratories' (NSE:DIVISLAB) Earnings  simplywall.st

Investors Shouldn't Be Too Comfortable With Divi's Laboratories' (NSE:DIVISLAB) Earnings - simplywall.st

Click here to get full coverage on Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act - Trade Brains

Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act  Trade Brains

Divis Lab and 5 other CDMO stocks to keep on your radar as US Senate passes Biosecure Act - Trade Brains

Click here to get full coverage on divis lab brokerage bullish triggers for uptrend - Zee Business

divis lab brokerage bullish triggers for uptrend  Zee Business

divis lab brokerage bullish triggers for uptrend - Zee Business

Click here to get full coverage on Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings - CNBC TV18

Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings  CNBC TV18

Divi's Laboratories shares fall 4% after IIFL warns of material risk to earnings - CNBC TV18

Click here to get full coverage on Divis Lab inks long-term global pharma deal - Business Standard

Divis Lab inks long-term global pharma deal  Business Standard

Divis Lab inks long-term global pharma deal - Business Standard

Click here to get full coverage on Divi's Laboratories Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st

Divi's Laboratories Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next  simplywall.st

Divi's Laboratories Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st

Click here to get full coverage on Divis Lab gains as broker reiterates buy call - Business Standard

Divis Lab gains as broker reiterates buy call  Business Standard

Divis Lab gains as broker reiterates buy call - Business Standard

Click here to get full coverage on Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years - simplywall.st

Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years  simplywall.st

Divi's Laboratories (NSE:DIVISLAB) shareholders have earned a 17% CAGR over the last five years - simplywall.st

Click here to get full coverage on Divi's Laboratories (NSE:DIVISLAB) Seems To Use Debt Quite Sensibly - simplywall.st

Divi's Laboratories (NSE:DIVISLAB) Seems To Use Debt Quite Sensibly  simplywall.st

Divi's Laboratories (NSE:DIVISLAB) Seems To Use Debt Quite Sensibly - simplywall.st

Click here to get full coverage on Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days - simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days  simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Stock Goes Ex-Dividend In Just Three Days - simplywall.st

Click here to get full coverage on Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation  simplywall.st

Most Shareholders Will Probably Agree With Divi's Laboratories Limited's (NSE:DIVISLAB) CEO Compensation - simplywall.st

Click here to get full coverage on With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently  simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

Click here to get full coverage on Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share  Business Standard

Divis Lab Q4 PAT climbs 23% YoY to Rs 662 cr; recommends final dividend of Rs 30/ share - Business Standard

Click here to get full coverage on Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14% - The Economic Times

Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14%  The Economic Times

Divi’s Laboratories Q1 Results: Cons net profit rises 27% YoY to Rs 545 crore, revenue up 14% - The Economic Times

Click here to get full coverage on Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages' Radar - NDTV Profit

Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages' Radar  NDTV Profit

Stock Picks Today: Trent, Bajaj Auto, Divis Lab, Lupin On Brokerages' Radar - NDTV Profit

Click here to get full coverage on Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.  Business Standard

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co. - Business Standard

Click here to get full coverage on Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB  Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Click here to get full coverage on Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict  Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Click here to get full coverage on NSE ONGC, DIVISLAB & UPL – Trading Insight - Moneymunch

NSE ONGC, DIVISLAB & UPL – Trading Insight  Moneymunch

NSE ONGC, DIVISLAB & UPL – Trading Insight - Moneymunch

Click here to get full coverage on Divis Lab spurts as broker maintains buy call - Business Standard

Divis Lab spurts as broker maintains buy call  Business Standard

Divis Lab spurts as broker maintains buy call - Business Standard

Click here to get full coverage on Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend  CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Click here to get full coverage on Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today - Markets Mojo

Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today  Markets Mojo

Divis Laboratories Ltd Sees Rs 63.52 Crores in Total Traded Value Today - Markets Mojo

Click here to get full coverage on Divis Labs Share Price Highlights: Divis Labs Stock Price History - The Economic Times

Divis Labs Share Price Highlights: Divis Labs Stock Price History  The Economic Times

Divis Labs Share Price Highlights: Divis Labs Stock Price History - The Economic Times

Click here to get full coverage on Divis Laboratories Sees 14.91% Surge in Open Interest to 45,151 Contracts - Markets Mojo

Divis Laboratories Sees 14.91% Surge in Open Interest to 45,151 Contracts  Markets Mojo

Divis Laboratories Sees 14.91% Surge in Open Interest to 45,151 Contracts - Markets Mojo

Click here to get full coverage on Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12% - The Economic Times

Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%  The Economic Times

Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12% - The Economic Times

Click here to get full coverage on Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today - Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today  Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 24,400.43 Lakhs Traded Today - Markets Mojo

Click here to get full coverage on Q2 results: Bajaj Auto, Divis Lab, Hindalco, Trent, Nykaa, Kalyan Jewellers, NALCO, others to declare earnings on Nov 7; check list - Upstox

Q2 results: Bajaj Auto, Divis Lab, Hindalco, Trent, Nykaa, Kalyan Jewellers, NALCO, others to declare earnings on Nov 7; check list  Upstox

Q2 results: Bajaj Auto, Divis Lab, Hindalco, Trent, Nykaa, Kalyan Jewellers, NALCO, others to declare earnings on Nov 7; check list - Upstox

Click here to get full coverage on Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - HDFC Sky

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr  HDFC Sky

Divi’s Labs Q1FY26 PAT Jumps 26.7% to ₹545 Cr - HDFC Sky

Click here to get full coverage on Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside  Zee Business

Anil Singhvi's Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Click here to get full coverage on Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive' - TradingView

Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive'  TradingView

Divi's Labs, Lupin, other pharma stocks rise up to 4%; here's why HDFC Securities says sector looks 'attractive' - TradingView

Click here to get full coverage on Divi's Lab stock slips on US supply worries - The Economic Times

Divi's Lab stock slips on US supply worries  The Economic Times

Divi's Lab stock slips on US supply worries - The Economic Times

Click here to get full coverage on Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors?  Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Click here to get full coverage on Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 14,927.06 Lakhs Traded Today - Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 14,927.06 Lakhs Traded Today  Markets Mojo

Divis Laboratories Ltd Ranks Among Most Active Stocks with Rs 14,927.06 Lakhs Traded Today - Markets Mojo

Click here to get full coverage on Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target - Moneycontrol

Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target  Moneycontrol

Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target - Moneycontrol

Click here to get full coverage on Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR - Business Standard

Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR  Business Standard

Dixon, MCX, Divis Lab: Trading strategies in F&O stocks with high PCR - Business Standard

Click here to get full coverage on Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25%  The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Click here to get full coverage on Why Divis Lab Share Price is Falling - Equitymaster

Why Divis Lab Share Price is Falling  Equitymaster

Why Divis Lab Share Price is Falling - Equitymaster

Click here to get full coverage on Indian pharma industry: A comparative analysis of Sun Pharma and Divi's Laboratories - Upstox

Indian pharma industry: A comparative analysis of Sun Pharma and Divi's Laboratories  Upstox

Indian pharma industry: A comparative analysis of Sun Pharma and Divi's Laboratories - Upstox

Click here to get full coverage on Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25% - Upstox

Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25%  Upstox

Divi's Laboratories Q3 net profit up 64.5% to ₹589 crore, revenue rises 25% - Upstox

Click here to get full coverage on Stocks to BUY: Top 6 Brokerage picks with high returns backed by strong fundamentals; Tata Power and ITC in the list - Zee Business

Stocks to BUY: Top 6 Brokerage picks with high returns backed by strong fundamentals; Tata Power and ITC in the list  Zee Business

Stocks to BUY: Top 6 Brokerage picks with high returns backed by strong fundamentals; Tata Power and ITC in the list - Zee Business

Click here to get full coverage on TRADESETUP – BANKNIFTY, DIVISLAB, ENDURANCE & More - Moneymunch

TRADESETUP – BANKNIFTY, DIVISLAB, ENDURANCE & More  Moneymunch

TRADESETUP – BANKNIFTY, DIVISLAB, ENDURANCE & More - Moneymunch

Click here to get full coverage on Divis Laboratories Q4 Results - Profit Surges 78% Y-o-Y Rs. 895 Crore - Groww

Divis Laboratories Q4 Results - Profit Surges 78% Y-o-Y Rs. 895 Crore  Groww

Divis Laboratories Q4 Results - Profit Surges 78% Y-o-Y Rs. 895 Crore - Groww

Click here to get full coverage on Divi's Lab, Syngene International, other pharma CDMO stocks fall as US softens stance on Biosecure Act - Upstox

Divi's Lab, Syngene International, other pharma CDMO stocks fall as US softens stance on Biosecure Act  Upstox

Divi's Lab, Syngene International, other pharma CDMO stocks fall as US softens stance on Biosecure Act - Upstox

Click here to get full coverage on Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?  The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Click here to get full coverage on Why Divi's Lab Share is Falling - Equitymaster

Why Divi's Lab Share is Falling  Equitymaster

Why Divi's Lab Share is Falling - Equitymaster

Click here to get full coverage on Q1 Results Highlights 6 August 2025: BHEL loss widens; Hero Motocorp profit flat; Trent profit rises; Blue Star PAT declines; PVR Inox narrows loss; Pidilite, Bajaj Auto profit up - BusinessLine

Q1 Results Highlights 6 August 2025: BHEL loss widens; Hero Motocorp profit flat; Trent profit rises; Blue Star PAT declines; PVR Inox narrows loss; Pidilite, Bajaj Auto profit up  BusinessLine

Q1 Results Highlights 6 August 2025: BHEL loss widens; Hero Motocorp profit flat; Trent profit rises; Blue Star PAT declines; PVR Inox narrows loss; Pidilite, Bajaj Auto profit up - BusinessLine

Click here to get full coverage on Divis Lab: GLP-1 opportunity to unfold in the medium term - Moneycontrol

Divis Lab: GLP-1 opportunity to unfold in the medium term  Moneycontrol

DIVISLAB

Price Chart

Key Statistics

Technicals

About DIVISLAB

Latest News

Should Weakness in Divi's Laboratories Limited's (NSE:DIVISLAB) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st

Earnings Not Telling The Story For Divi's Laboratories Limited (NSE:DIVISLAB) - simplywall.st

India's Divi's Laboratories up; Citi calls it their 'top pick' - TradingView

Advanced Charts

Top Gainers

Top Losers